INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2020

Dietary interventions including PUFAs and antioxidants show uncertain or little to no effect on multiple sclerosis relapses or disability progression.

A Cochrane systematic review evaluated 30 trials covering PUFA supplementation, antioxidants, dietary programs, and other supplements for multiple sclerosis. Comparing PUFAs with MUFAs showed very uncertain evidence regarding relapses (RR 1.02, 95% CI 0.88 to 1.20; 3 studies, 217 participants) and low-certainty evidence of little to no difference in global impression of deterioration (RR 0.85, 95% CI 0.71 to 1.03; 4 studies, 542 participants). Antioxidant supplementation compared to placebo also showed little to no difference in relapses (RR 0.98, 95% CI 0.59 to 1.64; 4 studies, 345 participants) and very uncertain effects on EDSS change (MD -0.19, 95% CI -0.49 to 0.11; 6 studies, 490 participants). All included trials had at least one methodological issue leading to unknown or high risk of bias.

Study type
Systematic review and meta-analysis of RCTs/CCTs
Who was studied
Adults with multiple sclerosis across 30 trials (Europe, North America, Middle East)
What was measured
Relapses, disability progression (EDSS), MRI activity, safety/adverse events

THE PAPER

Dietary interventions for multiple sclerosis-related outcomes.

Parks NE, Jackson-Tarlton CS, Vacchi L, Merdad R, Johnston BC. Cochrane Database Syst Rev, 2020.

PubMed 32428983 ↗DOI 10.1002/14651858.cd004192.pub3 ↗

Brain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.